Mitochondrial Heteroplasmy Shifting as a Potential Biomarker of Cancer Progression.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Jul 2021
Historique:
received: 24 05 2021
revised: 25 06 2021
accepted: 28 06 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 11 8 2021
Statut: epublish

Résumé

Cancer is a serious health problem with a high mortality rate worldwide. Given the relevance of mitochondria in numerous physiological and pathological mechanisms, such as adenosine triphosphate (ATP) synthesis, apoptosis, metabolism, cancer progression and drug resistance, mitochondrial genome (mtDNA) analysis has become of great interest in the study of human diseases, including cancer. To date, a high number of variants and mutations have been identified in different types of tumors, which coexist with normal alleles, a phenomenon named heteroplasmy. This mechanism is considered an intermediate state between the fixation or elimination of the acquired mutations. It is suggested that mutations, which confer adaptive advantages to tumor growth and invasion, are enriched in malignant cells. Notably, many recent studies have reported a heteroplasmy-shifting phenomenon as a potential shaper in tumor progression and treatment response, and we suggest that each cancer type also has a unique mitochondrial heteroplasmy-shifting profile. So far, a plethora of data evidencing correlations among heteroplasmy and cancer-related phenotypes are available, but still, not authentic demonstrations, and whether the heteroplasmy or the variation in mtDNA copy number (mtCNV) in cancer are cause or consequence remained unknown. Further studies are needed to support these findings and decipher their clinical implications and impact in the field of drug discovery aimed at treating human cancer.

Identifiants

pubmed: 34298989
pii: ijms22147369
doi: 10.3390/ijms22147369
pmc: PMC8304746
pii:
doi:

Substances chimiques

Biomarkers 0
DNA Restriction Enzymes EC 3.1.21.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto Nacional de Medicina Genómica
ID : 24/2016/I

Références

EMBO Mol Med. 2014 Apr;6(4):458-66
pubmed: 24567072
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6496-505
pubmed: 26561581
Symp Soc Exp Biol. 1975;(29):21-38
pubmed: 822529
Mitochondrion. 2019 May;46:361-369
pubmed: 30261279
Sci Rep. 2019 Apr 8;9(1):5752
pubmed: 30962477
Genes (Basel). 2020 Feb 18;11(2):
pubmed: 32085658
Oncol Rep. 2013 Dec;30(6):3006-12
pubmed: 24101028
Cancer Genet Cytogenet. 2008 Feb;181(1):16-9
pubmed: 18262047
Oncogene. 2006 Aug 7;25(34):4647-62
pubmed: 16892079
Front Immunol. 2021 Feb 09;11:628576
pubmed: 33633746
Nature. 2010 Mar 25;464(7288):610-4
pubmed: 20200521
Carcinogenesis. 2015 Nov;36(11):1307-13
pubmed: 26363030
Mol Cell. 2016 Mar 3;61(5):667-676
pubmed: 26942671
Nature. 2020 Jul;583(7817):631-637
pubmed: 32641830
Elife. 2015 Jun 02;4:e07464
pubmed: 26035426
Oncotarget. 2016 May 24;7(21):31270-83
pubmed: 27121313
PLoS Genet. 2015 Jun 30;11(6):e1005333
pubmed: 26125550
In Vivo. 2021 Jan-Feb;35(1):181-189
pubmed: 33402465
Oncotarget. 2021 Mar 30;12(7):674-685
pubmed: 33868588
IUBMB Life. 2018 Dec;70(12):1233-1239
pubmed: 30184317
Cell. 2015 Apr 23;161(3):459-469
pubmed: 25910206
Handb Exp Pharmacol. 2017;240:211-227
pubmed: 27718058
Mol Ther. 2015 Oct;23(10):1592-9
pubmed: 26159306
Oncol Lett. 2016 Nov;12(5):3081-3088
pubmed: 27899967
Adv Exp Med Biol. 2020;1245:67-83
pubmed: 32266653
Mol Aspects Med. 2010 Apr;31(2):145-70
pubmed: 20206201
Science. 2008 May 2;320(5876):661-4
pubmed: 18388260
Animals (Basel). 2020 Apr 11;10(4):
pubmed: 32290485
Sci Rep. 2018 Aug 8;8(1):11887
pubmed: 30089816
Trends Genet. 2018 Feb;34(2):101-110
pubmed: 29179920
Cell Metab. 2021 Feb 2;33(2):270-282.e8
pubmed: 33278339
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nutr Metab Cardiovasc Dis. 2020 Jun 9;30(6):960-966
pubmed: 32402592
Sci Rep. 2020 Jan 14;10(1):211
pubmed: 31937820
Front Oncol. 2020 Oct 27;10:572954
pubmed: 33194675
Ageing Res Rev. 2017 Jan;33:89-104
pubmed: 27143693
Genetics. 2005 Nov;171(3):1387-96
pubmed: 16079242
Nature. 1981 Apr 9;290(5806):457-65
pubmed: 7219534
Mitochondrion. 2020 Jul;53:214-223
pubmed: 32544465
Int J Oncol. 2018 Sep;53(3):923-936
pubmed: 30015870
Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14392-7
pubmed: 16179392
Breast Cancer Res Treat. 2010 Jun;121(2):511-8
pubmed: 19266278
Cancer Epidemiol. 2020 Oct;68:101778
pubmed: 32674053
PLoS Genet. 2020 Dec 14;16(12):e1009242
pubmed: 33315859
Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):686-699
pubmed: 28161329
Hum Genet. 2021 Jun;140(6):863
pubmed: 33547498
Clin Epigenetics. 2020 Nov 23;12(1):182
pubmed: 33228792
EMBO Rep. 2020 Mar 4;21(3):e49612
pubmed: 32073748
Neoplasia. 2018 Jul;20(7):687-696
pubmed: 29842994
Nat Cell Biol. 2018 Feb;20(2):144-151
pubmed: 29335530
Mitochondrion. 2015 Jan;20:13-21
pubmed: 25446395
Cell Stress. 2020 May 11;4(6):114-146
pubmed: 32548570
Stem Cells Int. 2020 Jul 7;2020:8838046
pubmed: 32724315
Gastroenterology. 2018 May;154(6):1620-1624.e5
pubmed: 29378198
Comput Biol Med. 2021 Jul;134:104473
pubmed: 34034219
Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):E4033-42
pubmed: 25192935
Cancer Med. 2018 Jun;7(6):2776-2782
pubmed: 29673117
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):16028-16035
pubmed: 31253706
Genome Res. 2019 Nov;29(11):1878-1888
pubmed: 31548359
BMC Cancer. 2004 Jul 01;4:30
pubmed: 15230979
Sci Rep. 2018 Apr 12;8(1):5872
pubmed: 29651131
Semin Cancer Biol. 2020 Oct 6;:
pubmed: 33035656
Open Med (Wars). 2021 Apr 21;16(1):660-671
pubmed: 33981850
Int J Cancer. 2018 May 1;142(9):1786-1796
pubmed: 29226320
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25172-25178
pubmed: 31757848
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10654-9
pubmed: 25002485
J Pathol. 2012 Jun;227(2):189-99
pubmed: 22190257
Am J Hum Genet. 2010 Dec 10;87(6):802-12
pubmed: 21129724
FEBS Lett. 2021 Apr;595(8):1184-1204
pubmed: 33742459
Int J Epidemiol. 2012 Feb;41(1):177-87
pubmed: 22287136
J Physiol Anthropol. 2016 Apr 29;35:12
pubmed: 27130215
BMC Med Genet. 2011 Jan 13;12:8
pubmed: 21232124
Semin Cell Dev Biol. 2020 Jan;97:156-166
pubmed: 31611080
Cancers (Basel). 2021 May 24;13(11):
pubmed: 34073868
Sci Signal. 2021 Jan 05;14(664):
pubmed: 33402335
Cancer Lett. 2020 Feb 28;471:49-60
pubmed: 31830557
Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):681-686
pubmed: 31932413
Sci Adv. 2020 Jul 29;6(31):eaba5345
pubmed: 32832682
Cancer Res. 2017 Nov 15;77(22):6051-6059
pubmed: 29097610
Biosci Rep. 2007 Jun;27(1-3):125-37
pubmed: 17486439
Cancer Res. 2017 Nov 15;77(22):6202-6214
pubmed: 28663334
Elife. 2014 Oct 01;3:
pubmed: 25271376
Prostate. 2016 Mar;76(4):349-58
pubmed: 26660354
Trends Cell Biol. 2019 Mar;29(3):227-240
pubmed: 30509558
Nat Commun. 2018 Aug 28;9(1):3490
pubmed: 30154431
PLoS One. 2017 Apr 28;12(4):e0176795
pubmed: 28453550
Int J Mol Sci. 2021 Jan 08;22(2):
pubmed: 33435522
Cancer Res. 2018 Feb 1;78(3):631-644
pubmed: 29229600
Nat Rev Mol Cell Biol. 2013 Jan;14(1):49-55
pubmed: 23169466
PLoS One. 2015 Aug 25;10(8):e0136216
pubmed: 26305705
Mitochondrion. 2019 Jan;44:85-92
pubmed: 29339192
Adv Cancer Res. 2019;142:63-105
pubmed: 30885364
Transl Res. 2018 Dec;202:24-34
pubmed: 30044960
Int J Mol Med. 2021 Jan;47(1):161-170
pubmed: 33416107
Hum Mol Genet. 2008 Jun 15;17(12):1814-20
pubmed: 18337306
Cancers (Basel). 2020 Jul 17;12(7):
pubmed: 32708892
J Cell Physiol. 2014 Jun;229(6):705-10
pubmed: 24590963
Cancer Metastasis Rev. 2018 Dec;37(4):615-632
pubmed: 30542781
Biomed Rep. 2016 Mar;4(3):259-262
pubmed: 26998260
Trends Mol Med. 2020 Jul;26(7):698-709
pubmed: 32589937
Anticancer Res. 2014 Apr;34(4):1467-82
pubmed: 24692674
Mutat Res. 2006 Jul 25;599(1-2):11-20
pubmed: 16490220
Gene Ther. 2012 Nov;19(11):1101-6
pubmed: 22130448
Biochim Biophys Acta. 2013 Dec;1836(2):336-44
pubmed: 24140413
Nat Med. 2013 Sep;19(9):1111-3
pubmed: 23913125
Bio Protoc. 2017 May 5;7(9):
pubmed: 28534038
Mol Med Rep. 2012 Jul;6(1):125-30
pubmed: 22505229
Mitochondrion. 2016 Jan;26:104-12
pubmed: 26678158
Biomater Sci. 2018 Nov 1;6(11):2786-2797
pubmed: 30182102
Free Radic Biol Med. 2021 Jul;170:59-69
pubmed: 33271282
Oncol Rep. 2018 Dec;40(6):3694-3704
pubmed: 30272316
Future Med Chem. 2017 Dec;9(18):2197-2210
pubmed: 29182013
J Exp Clin Cancer Res. 2019 Jan 23;38(1):30
pubmed: 30674338
Nucleic Acids Res. 2019 Nov 4;47(19):10072-10085
pubmed: 31665742
Commun Biol. 2021 May 14;4(1):584
pubmed: 33990696
Nucleic Acids Res. 2016 Sep 19;44(16):7804-16
pubmed: 27466392
Nat Commun. 2018 Jun 27;9(1):2488
pubmed: 29950599
Ann N Y Acad Sci. 2010 Jul;1201:40-3
pubmed: 20649537
J Intern Med. 2020 Jun;287(6):685-697
pubmed: 32176378
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19689-94
pubmed: 17170133
Blood. 2017 Oct 5;130(14):1649-1660
pubmed: 28733324
Oxid Med Cell Longev. 2017;2017:8060949
pubmed: 28680532
Anticancer Agents Med Chem. 2021 Jan 12;:
pubmed: 33438558
J Biol Chem. 2014 May 9;289(19):13323-34
pubmed: 24692550
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2491-6
pubmed: 25675502
Hypoxia (Auckl). 2015 Dec 11;3:83-92
pubmed: 27774485
Int J Mol Sci. 2020 Aug 21;21(17):
pubmed: 32825551
Int J Mol Sci. 2021 Mar 23;22(6):
pubmed: 33806730
Adv Exp Med Biol. 2019;1158:257-267
pubmed: 31452145
Curr Genet. 2014 Feb;60(1):11-6
pubmed: 23842853
Anal Chem. 2019 Aug 6;91(15):9885-9892
pubmed: 31310097
Hum Mol Genet. 2001 Dec 15;10(26):3093-9
pubmed: 11751691
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):719-24
pubmed: 15647368
Essays Biochem. 2018 Jul 20;62(3):455-465
pubmed: 29950320
Front Oncol. 2021 May 20;11:668731
pubmed: 34094963
Nat Commun. 2019 Aug 21;10(1):3763
pubmed: 31434891
Nat Commun. 2018 Apr 30;9(1):1727
pubmed: 29712893
Cold Spring Harb Symp Quant Biol. 2011;76:1-16
pubmed: 22194359
Cancer Res. 2005 Sep 1;65(17):8028-33
pubmed: 16140977
Oncol Rev. 2019 Apr 16;13(1):409
pubmed: 31044027
J Theor Biol. 1967 Mar;14(3):255-74
pubmed: 11541392
Nat Rev Mol Cell Biol. 2021 Jan;22(1):54-70
pubmed: 33093673
Genes Chromosomes Cancer. 2005 Sep;44(1):19-28
pubmed: 15892105
Neurochem Res. 2019 Jan;44(1):22-37
pubmed: 30027365
Nat Genet. 2020 Mar;52(3):342-352
pubmed: 32024997
Nat Med. 2018 Nov;24(11):1691-1695
pubmed: 30250142
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Nat Commun. 2017 Sep 22;8(1):656
pubmed: 28939825
Front Endocrinol (Lausanne). 2019 Jul 02;10:421
pubmed: 31312182
Oncol Rep. 2015 Jun;33(6):2924-34
pubmed: 25845386
Sci Rep. 2020 Jun 29;10(1):10592
pubmed: 32601317
Oncotarget. 2017 Sep 16;8(48):84373-84383
pubmed: 29137431
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3630-5
pubmed: 21321201
Hum Mol Genet. 2017 Aug 1;26(15):2912-2922
pubmed: 28475717
Hum Mutat. 2018 May;39(5):691-701
pubmed: 29330893
Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165648
pubmed: 31899295
J Intern Med. 2020 Jun;287(6):634-644
pubmed: 32187761
APMIS. 2015 Dec;123(12):1048-54
pubmed: 26547371
ACS Chem Biol. 2018 Apr 20;13(4):900-908
pubmed: 29509408
Hum Mol Genet. 1999 Jun;8(6):1047-52
pubmed: 10332036
Nat Rev Genet. 2021 Feb;22(2):106-118
pubmed: 32989265
Elife. 2016 Feb 22;5:
pubmed: 26901439
Essays Biochem. 2018 Jul 20;62(3):225-234
pubmed: 29880721
Sci Rep. 2018 Jun 22;8(1):9500
pubmed: 29934612
Adv Exp Med Biol. 2017;982:577-594
pubmed: 28551808
Biochem J. 2018 Jul 31;475(14):2305-2328
pubmed: 30064989
Biomed Res Int. 2015;2015:305716
pubmed: 26448933
Int J Cancer. 2005 Oct 10;116(6):920-4
pubmed: 15856456
Carcinogenesis. 2014 May;35(5):1046-54
pubmed: 24442641
Nat Rev Cancer. 2012 Oct;12(10):685-98
pubmed: 23001348
Hum Mol Genet. 2019 Oct 1;28(19):3163-3174
pubmed: 31261379
PLoS One. 2020 Sep 24;15(9):e0233666
pubmed: 32970680
Nucleic Acids Res. 2008 Jul;36(12):3926-38
pubmed: 18511461
FEBS Lett. 2021 Apr;595(8):976-1002
pubmed: 33314045
Genome Biol Evol. 2019 Oct 1;11(10):2909-2916
pubmed: 31599941
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Front Oncol. 2021 May 10;11:672781
pubmed: 34041035
DNA Repair (Amst). 2020 Sep;93:102916
pubmed: 33087282

Auteurs

Carlos Jhovani Pérez-Amado (CJ)

Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Programa de Maestría y Doctorado, Posgrado en Ciencias Bioquímicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.

Amellalli Bazan-Cordoba (A)

Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Programa de Maestría y Doctorado, Posgrado en Ciencias Bioquímicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.

Alfredo Hidalgo-Miranda (A)

Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.

Silvia Jiménez-Morales (S)

Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH